Free Trial
NASDAQ:NTHI

Neonc Technologies Q2 2026 Earnings Results & Report

Neonc Technologies logo
$2.66 +0.06 (+2.31%)
Closing price 04:00 PM Eastern
Extended Trading
$2.70 +0.04 (+1.50%)
As of 06:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Neonc Technologies missed analyst earnings expectations in its Q2 2026 results, released August 10, 2026. The company reported EPS of -$0.58 versus the -$0.1167 consensus estimate.

Earnings Announcement Details

Quarter
Q2 2026
Report Date
Time
Before Market Opens
Conference Call
7:00 AM ET

Neonc Technologies EPS Results

Actual EPS
-$0.58
Consensus EPS
-$0.1167
Beat/Miss
Missed by -$0.4633
One Year Ago EPS
N/A

Neonc Technologies Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Upcoming Earnings

Neonc Technologies' Q3 2026 earnings is estimated for Thursday, November 12, 2026, based on past reporting schedules, with a conference call scheduled on Tuesday, November 10, 2026 at 9:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Neonc Technologies Q2 2026 Earnings FAQ

Neonc Technologies (NASDAQ:NTHI) reported earnings of -$0.58 per share for Q2 2026, missing the consensus estimate of -$0.1167. The report was announced on Monday, August 10, 2026.

Neonc Technologies' next earnings date is estimated for Thursday, November 12, 2026. MarketBeat tracks confirmed and estimated earnings dates for Neonc Technologies on the company's earnings history page.

Neonc Technologies Earnings Headlines

NeOnc Technologies Appoints Ali Alabedin to Its Board of Directors
Why Some AI Stocks Already Surged Over 300 Percent
Jason Bodner's system flagged Nvidia before a 7000 percent run, Super Micro Computer before a 2600 percent run, and Vertiv before a 1900 percent run. Now he's tracking a radical light-speed technology that could make AI 100 times faster and 100 times more energy efficient. Stocks tied to it have already climbed 133 percent, 217 percent, and 320 percent.tc pixel
NeOnc’s FDA Catalyst Run Could Give NTHI a Serious Jolt
See More Neonc Technologies Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Neonc Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Neonc Technologies and other key companies, straight to your email.

About Neonc Technologies

Neonc Technologies (NASDAQ:NTHI) develops novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. Its lead products in development include NEO100, which is in Phase 2a clinical trials for treating glioblastoma; and NEO212, a covalently conjugated molecule combining the chemotherapeutic drug temozolomide with perillyl alcohol that is completed preclinical testing. The company was incorporated in 2023 and is based in Los Angeles, California.

View Neonc Technologies Profile